Related Experiment Video
Updated: Aug 20, 2025

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina
Published on: March 14, 2025
Effect of neonatal reticulocytosis on glucose 6-phosphate dehydrogenase (G6PD) activity and G6PD deficiency
Thanaporn Pimpakan1, Punchalee Mungkalasut2, Pornchinee Tansakul1
1Medical Sciences Program, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Insights
Screening newborns for G6PD deficiency is crucial. This study found that high reticulocyte counts do not significantly impact the accurate diagnosis of G6PD deficiency in newborns using automated methods.
Area of Science:
- Biochemistry
- Genetics
- Neonatal Medicine
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency screening in newborns is vital for preventing severe health issues like hemolysis and bilirubin encephalopathy.
- High reticulocyte counts in newborns may potentially interfere with G6PD deficiency diagnosis due to higher enzyme levels in immature red blood cells.
Purpose of the Study:
- To evaluate the influence of reticulocytosis on G6PD activity measurements in Thai newborns.
- To validate a novel automated UV-based enzymatic assay for G6PD deficiency detection in neonates.
Main Methods:
- Measured reticulocyte counts and G6PD activity in 1,015 newborn blood samples.
- Identified G6PD mutations using TaqMan SNP genotyping, PCR-RFLP, and direct sequencing.
- Assessed the correlation between reticulocyte levels and G6PD activity, and compared the automated assay's performance against the fluorescent spot test and standard quantitative assay.
Main Results:
- The automated assay identified G6PD deficiency in 6.5% of newborns, comparable to 5.3% (FST) and 6.1% (standard method).
- Newborns with G6PD deficiency exhibited significantly higher reticulocyte counts (p < 0.001).
- The automated method demonstrated high accuracy (99.4%), sensitivity (98.4%), and specificity (99.5%) in detecting G6PD deficiency.
Conclusions:
- Reticulocytosis does not significantly affect the accurate diagnosis of G6PD deficiency in newborns.
- The novel automated UV-based enzymatic assay is a reliable tool for G6PD deficiency screening in neonates.
Background:
Screening for G6PD deficiency in newborns can help prevent severe hemolysis, hyperbilirubinemia, and bilirubin encephalopathy, as recommended by the World Health Organization (WHO). It has been speculated that the presence of a high number of reticulocytes in newborns interferes with the diagnosis of G6PD deficiency since reticulocytes contain higher amounts of G6PD enzyme than mature erythrocytes. Therefore, the purposes of this study were to assess the effect of reticulocytosis in the determination of blood G6PD activity in Thai newborns by using a novel automated UV-based enzymatic assay and to validate the performance of this assay for the detection of G6PD deficiency in newborn samples.
Methods:
The levels of reticulocytes and G6PD activity were measured in blood samples collected from 1,015 newborns. G6PD mutations were identified using TaqMan® SNP genotyping assay, PCR-restriction fragment length polymorphism (PCR-RFLP), and direct sequencing. The correlation between the levels of reticulocytes and G6PD activity was examined. The performance of the automated method was compared with that of the fluorescent spot test (FST) and the standard quantitative assay.
Results:
The automated assay detected G6PD deficiency in 6.5% of the total newborn subjects compared to 5.3% and 6.1% by the FST and the standard method, respectively. The minor allele frequencies (MAFs) of G6PD ViangchanG871A, G6PD MahidolG487A, and G6PD UnionC1360T were 0.066, 0.005, and 0.005, respectively. The reticulocyte counts in newborns with G6PD deficiency were significantly higher than those in normal male newborns (p < 0.001). Compared with normal newborns after controlling for thalassemias and hemoglobinopathies, G6PD-deficient patients with the G6PD ViangchanG871A mutation exhibited elevated reticulocyte counts (5.82 ± 1.73%, p < 0.001). In a group of G6PD normal newborns, the percentage of reticulocytes was positively correlated with G6PD activity (r = 0.327, p < 0.001). However, there was no correlation between G6PD activity and the levels of reticulocytes in subjects with G6PD deficiency (r = -0.019, p = 0.881). The level of agreement in the detection of G6PD deficiency was 0.999, while the area under the receiver operating characteristic (AUC) curve demonstrated that the automated method had 98.4% sensitivity, 99.5% specificity, 92.4% positive predictive value (PPV), 99.9% negative predictive value (NPV), and 99.4% accuracy.
Conclusions:
We report that reticulocytosis does not have a statistically significant effect on the detection of G6PD deficiency in newborns by both qualitative and quantitative methods.
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

